Cargando…
End-Stage Kidney Disease Resulting from Atypical Hemolytic Uremic Syndrome after Receiving AstraZeneca SARS-CoV-2 Vaccine: A Case Report
Hemolytic uremic syndrome (HUS) is classically described as a triad of nonimmune hemolytic anemia, thrombocytopenia, and acute kidney injury. Atypical HUS (aHUS) is a rare variant of the disease, and it accounts for 5–10% of the cases. It has a poor prognosis, with a mortality rate exceeding 25% and...
Autores principales: | Tawhari, Mohammed, Alhamadh, Moustafa S., Alhabeeb, Abdulrahman Yousef, Almudayfir, Ziyad, Radwi, Mansoor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054544/ https://www.ncbi.nlm.nih.gov/pubmed/36992263 http://dx.doi.org/10.3390/vaccines11030679 |
Ejemplares similares
-
Renal Transplant Experience in a Tertiary Care Center in Saudi Arabia: A Retrospective Cohort Study
por: Tawhari, Mohammed, et al.
Publicado: (2022) -
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021) -
Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021)